HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin E

This article was originally published in The Rose Sheet

Executive Summary

Revenues of vitamin E in the cosmetics market segment is anticipated to reach $13.6 mil. in 2012, at a compound annual growth rate of 6.9%, consulting company Frost & Sullivan says in recently published analysis. Antioxidants for anti-aging applications, clinical studies, scar treatment and product innovation are market drivers, while restraints are small volumes and high pricing of vitamin E, according to firm. The cosmetics industry made up 4.1%, or $8.6 mil., of U.S. vitamin E revenues in 2005, according to firm. Vitamin E's total revenues were $209.6 mil. in 2005 and are estimated to reach $260.8 mil. in 2012, company notes...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013807

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel